A Study of Concurrent Chemoradiotherapy Based of Cisplatin With or Without Sintilimab as First-line Therapy for Patients With Advanced Oral Cavity Squamous Cell Carcinoma

NCT05749042 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Oral Cavity Squamous Cell Carcinoma

Interventions

DRUG: Sintilimab
RADIATION: Radiotherapy

Sponsor

Xin-Hua Xu